3531 - 3540 of 8571 Results
Title
Year
-
OPENTitle: The digital signature of emergent tremor in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00754-7Best OA location URL: https://www.nature.com/articles/s41531-024-00754-7.pdfCitation Count: 3
-
OPENTitle: Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12589Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12589Citation Count: 1
- Single-pulse subthalamic deep brain stimulation reduces premotor-motor facilitation in Parkinson's disease2019RESTRICTEDTitle: Single-pulse subthalamic deep brain stimulation reduces premotor-motor facilitation in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 224End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.08.003Citation Count: 3
- Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease2018OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145
-
OPENTitle: Olfactory identification in LRRK 2 G2019S mutation carriers: a relevant marker?Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 1Issue #: 9Start Page: 670End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.95Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.95Citation Count: 39
- The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation2024OPENTitle: The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 381Issue #:Start Page: 114926End Page: 114926Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114926Citation Count: 3
- Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors2019RESTRICTEDTitle: Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptorsJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 174Issue #:Start Page: 113788End Page: 113788Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2019.113788Citation Count: 5
- Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion2019OPENTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6443492Citation Count: 9
- Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries2023OPENTitle: Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiariesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 5Start Page: e0285011End Page: e0285011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0285011Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0285011&type=printableCitation Count: 6
- Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease2023OPENTitle: Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 899End Page: 903Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29342Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29342Citation Count: 13